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1. Introduction 
Symptoms of Gastroesophageal Reflux Disease (GERD) are both esophageal and 
extraesophageal symptoms. The consensus statements on the definition of GERD in the 
pediatric population were reported that respiratory symptoms might be occurred by 
gastroesophageal acid reflux (Sherman et al.,2009). But, the definition of GERD used by 
gastroenterologists are much different from that used by allergists (Colombo, 2004).  
Usually, the diagnosis of GERD is based on the reflux index (percentage of total recording 
time with a pH below 4) during 24-hour pH monitoring (pH monitoring) (Working group of 
the European society of pediatric gastroenterology and nutrition, 1992). But, this baseline of 
the reflux index was defined by gastroenterologists.In our previous study in asthmatic 
children with GERD, we showed that respiratory symptoms tended to worse not only at 
night but also in the daytime, and the index of the mean hourly number of acid refluxes (the 
mean number of acid reflux/h) which we defined parameters as the frequency of acid 
refluxes during upright position during pH monitoring was important for the diagnosis of 
GERD when associated with asthma (Yoshida et al., 2009).  
In some previous reports, the frequency of GERD in children with respiratory symptoms 
was comparatively high (Saglani et al., 2006). But, at the present situation, it has not been 
cleared sufficiently when GERD should be considered in children with episodes of recurrent 
wheezing. In clinically, when episodes of recurrent wheezing are intractable regardless of 
doing medications, we suspect that GERD is associated with episodes of recurrent 
wheezing. So, in the present study, we investigated the difference of characteristics for 
diagnosis and treatment of GERD more appropriately in children with episodes of recurrent 
wheezing associated with GERD. 
Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are widely 
used as acid suppression therapy of GERD (Scarupa et al.,2005). In recent years, not only 
H2RAs but also PPIs were reported for treatment of GERD (Gustafsson et al.,1992; Harper et 
al., 1987; Khoshoo et al.,2003; Sopo et al.,2009; Stordal et al.,2005; The American lung 
association asthma clinical research center,2009). However, in Japan, we can only use the 
enteric-coated tablet-type PPIs. Therefore, PPIs are difficult to use for preschool children 
especially those under 5 years of age. So, we have no choice but to use the powdered-type 
H2RAs in children under 5 years of age. In our country, the powdered-type H2RAs we can 
use is famotidine. So, in the present study, we used famotidine as acid suppression therapy. 
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And, in our previous study, the mean number of acid reflux/h during the upright position 
exceeded 7 in all the children with GERD associated asthma (Yoshida, et al., 2009). So, in the 
present study, we diagnosed of GERD by the mean number of acid reflux/h which baseline 
was defined as exceeded 7 and response of acid suppression therapy.  
2. Materials and methods 
We performed pH monitoring between June 2007 and December 2008 in 52 preschool 
children with episodes of recurrent wheezing. All participant’s chest radiograph were 
normal. They had no other respiratory disorders, for example, bronchiectasis, recurrent 
pneumonia, aspiration, intestinal lung disease and airway abnormality. And they had no 
neurological disorders, cardiac disease and  gastrointestinal symptoms. 
All patients received inhaled corticosteroid (ICS) for more than 3 months. The ICS used was 
fluticasone or hydrofluoroalkane-beclomethasone dipropionate more than 200 μg/day. But, 
their respiratory symptomatic days during one month were more than 5 days. Their 
respiratory symptoms were uncontrolled. So, we suspected that GERD was associated with 
their respiratory symptoms, and we performed the pH monitoring.  
When the mean number of acid refluxes/h during upright position exceeded 7, by the result 
of pH monitoring, we started famotidine therapy (0.5mg/kg twice daily). And, we followed 
up the children who started famotidine therapy for one month. So, we counted respiratory 
symptomatic days for one month before and after starting the famotidine therapy. And we 
compared them before and after starting the famotidine therapy. 
So, in the case that symptomatic days were decreased less than half days, we defined that 
framotidine therapy was effective. When famotidine therapy was effective, children formed 
the effective group. On the other hand, in the case that symptomatic days were not 
decreased less than half days, we defined that framotidine therapy was not effective. When 
famotidine therapy was not effective, children formed the no effective group. Then, we 
compared the patient’s characteristics between the two groups. We investigated the 
patient’s age, onset age of wheezing episodes, level of serum IgE, amount of ICS and results 
of pH monitoring as patient’s characteristics. And we investigated modified asthma 
predictive index (mAPI) as the risk factors for the development of asthma (Panettieri et al., 
2008). 
The pH monitoring was performed using a Synectics Digitrapper MKⅢ (Synetics Medical 
Stockholm Sweden). The catheter had 4 probes that sensed acid reflux. The most upper 
probe (the first probe) was 20 cm above the bottom probe. The third probe of the catheter 
was placed 3-4 cm above the gastroesophageal junction, and its position was checked by 
chest radiography. We examined the mean number of acid refluxes/h during upright 
position and the reflux index at the third probe. The asthma medication was continued as 
usual during pH monitoring. 
In our hospital, respiratory symptoms are recorded in a diary in order to acquire the precise 
clinical manifestation. At every patient’s visit, each physician checked the diary. 
3. Data analysis 
Normal distributed data were presented as mean ± SD. Nonparametric data were expressed 
as median. The differences were assessed by the Mann-Whitney U-test. A p-vale <0.05 was 
considered to be statistically significant for all tests. 
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4. Results 
Patient profiles were summarized in Table 1. 27 children showed the results that the mean 
number of acid reflux/h during upright position exceeded 7. In 18 of the 27 children, the 
reflux index exceeded 4%. In the remaining 25 children with the mean number of acid 
reflux/h during upright position being below 7, the reflux index was below 4%.  
 
Gender  
- Male,n 35 
- Female,n 17 
Age,years* 3.1 (1.8) 
Amount of ICS, μg/day* 219 (59.4) 
Results of 24-hour pH monitoring 
- Reflux index,%* 
 
6.2 (9.5) 
- The mean number of acid reflux/h during 
upright position, times* 
12.4 (13.6) 
- The number of children with reflux index 
over 4 %, n 
18 
- The number of children with the mean 
number of acid reflux/h  
during upright position over seven, n 
27 
*Data are presented as mean (SD). n:number.  ICS; inhaled corticosteroid 
Table 1. Patient profiles (n=52) 
19 of the 27 children profiles with the mean number of acid reflux/h during upright position 
being over 7 were summarized in Table 2. The remaining 8 children did not record 
respiratory symptoms in the diary or did not visit our hospital. Among the 19 children, 8 
were included in the effective group and 11 were included in the no effective group. 
 
Gender  
- Male,n 12 
- Female,n 7 
Age,year* 3.1 (1.33) 
Amount of ICS, μg/day* 235 (236) 
Results of 24-hour pH monitoring  
- The mean number of acid reflux/h during upright 
position, times* 
19.5 (19.9) 
- Reflux index,%* 9.0 (9.3) 
The effective group 8 
The no effective group 11 
*Data are presented as mean (SD). n:number.  ICS; inhaled corticosteroid 
Table 2. Patient profiles with the mean number of acid reflux/h during upright position 
over 7 (n=19) 
A comparison of patient’s characteristics between the effective group and the no effective 
group was summarized in Table 3. The mean (SD) age was 2.4 (1.0) years old in the effective 
group, and 3.5 (1.3) years old in the no effective group (p<0.05). And, the mean (SD) onset 
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 Effective group 
n=8 
No effective group 
n=11 
p vale 
Age,year 2.4(1.0) 3.5(1.3) p<0.05 
Onset age of episodes of  wheezing, year 1.0(1.1) 3.0(1.0) p<0.05 
Serum IgE, IU/ml 209(201) 150(237) n.s. 
Amount of ICS, μg/day 237(106) 236(80) n.s. 
Results of 24-hour pH monitoring    
- reflux index,% 11.4(10.8) 7.6(9.8) n.s. 
- The mean number of acid reflux/h 
during upright position, times 
20.9(9.5) 19.0(19.6) n.s. 
Respiratory symptomatic days    
- Before famotidine 16.0(7.2) 14.1(5.8) n.s. 
- After famotidine 5.6(5.4) 13.9(4.5) p<0.05 
Data are presented as mean(SD). 
Table 3. Comparison of the effective group and the no effective group 
age of wheezing was 1.0 (1.1) years old in the effective group, and 3.0 (1.0) years old in the 
no effective group (p<0.05). The mean (SD) respiratory symptomatic days before famotidine 
were 16.0 (7.2) in the effective group, and 14.1 (5.8) in the no effective group. The mean (SD) 
respiratory symptomatic days were 5.6 (5.4) in the effective group, and 13.9(4.5) in the no 
effective group (p<0.05). There was no significant difference between the two groups before 
famotidine tehapy. But, there was difference between the two groups after famotidine 
therapy. The changes of the respiratory symptomatic days between before and after 
famotidine therapy in each group were showed in figure 1. In the effective group, there was 
singinficant difference (p<0.05). There was no singinficant difference between the two 
groups about level of serum IgE, amount of ICS and the results of pH monitoring in Table 3.  
A comparison of modified asthma predictive index between the effective group the no 
effective group was summarized in Table 4. There was no singinficant difference about each 
index between the two groups. 
 
Modified Asthma Prediction Index 
Effective 
group (n=8) 
No effective group 
(n=11) 
p 
value 
• Major criteria, n     
Parental history of asthma 3 5 n.s. 
Physician-diagnosed atopic dermatitis 2 3 n.s. 
Allergic sensitization to ≧ 1 aeroallergen 5 6 n.s. 
• Minor criteria,n    
Allergic sensitization to milk, egg, or 
peanuts 
3 3 n.s. 
Wheezing unrelated to colds 8 11 n.s. 
Blood eosinophils ≧ 4% 5 5 n.s. 
The presence of 1 of the major criteria  
or 2 minor criteria,n  
8 
(100%) 
11 
(100%) 
 
Table 4. Comparison of Modified Asthma Prediction Index between the effective group and 
the no effective group 
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Fig. 1. The difference of the effective group and the no effective group of respiratory 
symptomatic days between before and after famotidine therapy 
5. Discussion 
The incidence of GERD was comparatively high in children with episodes of recurrent 
wheezing. The previous report had shown that the incidence of asthma in children with 
episodes of recurrent wheezing was 40.4%, and that of GERD was 23.4%. In particular, 57% 
children with asthma also had GERD (Saglani et al., 2006). But, the efficacy of acid 
suppression therapy was not cleared sufficiently for children with episodes of recurrent 
wheezing (Brand et al., 2008). For example, in the treatment of asthma, there was a report 
that PPIs did not improve asthma control (The American lung association asthma clinical 
research center, 2009). So, in the present study, we prescribed for famotidine based on result 
of pH monitoring in the lower age preschool children with episodes of recurrent wheezing, 
and compared between children with effective and ineffective of famotidine therapy. And, 
we showed that famotidine therapy could be more effective in the lower age preschool 
children with episodes of recurrent wheezing with associated GERD. 
In the present study, 8 out of 19 (42%) children who received the famotidine therapy were 
included the effective group. And, in the effective group, the mean age and the onset age of 
first wheezing episode were significantly lower than that of the no effective group. Namely, 
in preschool children with episodes of recurrent wheezing associated with GERD, the lower 
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age of and the lower onset age of first wheezing episodes were, the more effective 
famotidine therapy was. In clinically, a diagnosis of GERD is made by the efficacy of acid 
suppression therapy in addition to the results of pH monitoring. So, in the effective group, 
their respiratory symptoms could be defined that GERD was associated with episodes of 
recurrent wheezing. About relationship of gastroesophageal acid reflux (GER) and age, the 
other previous report had shown that GER occurs easily below one year of age (Nelson et 
al., 1997). From the present results and previous reports, we suggested that respiratory 
symptoms of lower age could be much associated with GERD witch symptoms were 
improved by famotidine in children with episodes of recurrent wheezing.  
Some previous reports had shown the efficacy of PPIs for children with episodes of 
recurrent wheezing (Sopo et al., 2009; Stordal et al., 2005). PPIs were more effective than 
H2RAs such as famotidine. But, PPIs available in Japan are difficult to use for preschool 
children. So, in the no effective group in the present study, there might be improved 
respiratory symptoms if PPIs were used. But, unfortunately, this problem could not be 
cleared in the present situation in Japan. 
But, there are two treatment regimens of GERD. One treatment regimen witch is called the 
no effective therapy is to begin with H2RAs. When symptoms are not improved by H2RAs, 
then PPIs are used. The other medication witch is called step-down therapy is to begin with 
PPIs. But, in treatment of GERD, cost-effectiveness considerations must be needed when 
which medication is used (Hassall, 2008). In general, PPIs are superior to H2RAs for erosive 
esophagitis (Vandenplas et al., 2009). So, PPIs were capable of being a cost-effective 
diagnostic test in adult (Ofman et al., 1999). But, in children, there was no study comparing 
these two medications (Hassall, 2008). In pediatric gastroesophageal reflux clinical practice 
guidelines, there needs special concern to prescription of PPIs in infants(Vandenplas et al., 
2009). In previous report, PPIs were used over the age of 2 years old or those with moderate 
symptoms of GERD. But, under the age of 12 month, H2RAs were better starting medication 
(Hassall, 2008; Vandenplas et al., 2009). So, in clinical cases, the medication is selected by 
considering age and severity of symptoms.  
About symptoms of GERD, the presence of esophageal erosions or ulcers is one of the 
factors that determine the severity of GERD (Armstrong et al., 2005). But, the previous study 
showed that the presence of esophagitis did not always exist in children with refractory 
respiratory symptoms of GERD (Ravelli et al., 2006). So, the severity of GERD with episodes 
of recurrent wheezing could be defined “mild”  
Another previous report showed that H2RAs were safe and effective for the management of 
mild GERD symptoms (Vandenplas et al., 2009). So, we suggested that H2RAs might be 
prescribed first for children with episodes of recurrent wheezing. H2RAs include cimetidine, 
famotidine and ranitidine. There was no previous study about the effective of famotidine for 
respiratory symptoms. So, our present study is valuable. 
Asthma is the most common cause in diseases with episodes of recurrent wheezing 
(Weinberger & Abu-Hasan, 2007). Recurrent wheezing during first 3 years is one of the 
established risk factor for the development of asthma in childhood (Panettieri et al., 2008). 
But, we must take careful of asthma like symptoms caused by other causes (Weinberger & 
Abu-Hasan, 2007). Diagnosis of asthma in preschool children with episodes of recurrent 
wheezing is difficult (Brand et al., 2008). The previous report had shown that the incidence 
of asthma in children with episodes of recurrent wheezing was 41%, and that of GERD was 
23%, and that of predominantly infection was 13% ( Saglani et al., 2006). One of the common 
diagnosis in the diseases of predominantly infection is protracted bacterial bronchitis 
(Gibson et al., 2010). Children with protracted bacterial bronchitis are sometimes erroneous 
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labeled as having severe asthma (Chang et al., 2008). So, the other previous report had 
shown that the differential diagnosis should be considered when young children with 
recurrent respiratory symptoms had a negative mAPI (Chipps, 2010). 
The mAPI is a clinical index of asthma for 2 years of age and older (Panettieri et al., 2008). 
When the child has the presence of 1 the major criteria or 2 minor criteria in the mAPI, the 
recurrent respiratory symptoms of child might be developed persistent asthma (Chipps, 
2010). So, we investigated mAPI whether there were differences about risk factor for asthma 
development between the effective group and the no effective group. As a result, there was 
no significant difference on each subject. And all children of each groups had the presence of 
1 of the major criteria or 2 minor criteria. So, there was no significant difference about risk 
factor for asthma development according to the mAPI. But, in the no effective group, 
amount of ICS was increased within 3 months after famotidine therapy for controlling of 
respiratory symptoms. The mean (SD) amount of ICS was 308 (78) μg/day. (data not 
shown). We speculated that children in the no effective group had more progressive airway 
inflammation and had more risk for asthma development than children in the effective 
group. But, it is not cleared sufficiently in the present study.  
6. Conclusion 
It is not cleared sufficiently that we must consider what kind of preschool children with 
episodes of recurrent wheezing are prescribed for the acid suppression therapy. In our 
present study, in preschool children with episodes of recurrent wheezing associated with 
GERD, the lower age of and the lower onset age of first wheezing episodes were, the more 
effective famotidine therapy was. We suggest that lower age preschool children with 
episodes of recurrent wheezing whose symptoms are suspected associating with GERD 
from the result of pH monitoring might be prescribed acid suppression therapy actively.  
And, famotidien is inferior to PPIs as the acid suppression therapy. But, we suggest that 
famotidine might be useful as primary medication for “mild” GERD which main symptom 
is recurrent wheezing. 
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